CTRI/2014/08/004939
Completed
未知
COMPARISON OF HEARING LOSS IN PATIENTS RECEIVING DIFFERENT MODALITIES OF RADIOTHERAPY I.E 2DRT, 3DRT AND IMRT IN HEAD AND NECK MALIGNANCIES
FATHER MULLER MEDICAL COLLEGE0 sites50 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- FATHER MULLER MEDICAL COLLEGE
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Individuals receiving either of the modalities of radiation for head and neck tumors where the auditory system is included in the field of radiation.
- •2\.Individuals coming for atleast 3 months follow up.
- •3\.Individuals willing to participate in the study.
Exclusion Criteria
- •Individuals who
- •have congenital hearing loss.
- •have undergone otological surgery in the past.
- •have a hearing loss of more than 55 dB prior to therapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of Hearing results after ossiculoplasty: titanium versus polycelChronic otitis media with ossicular disruption.Other acquired abnormalities of ear ossiclesIRCT201205049631N1Vice-Chancellery of Research and Technology100
Completed
Not Applicable
Comparison of Hearing results after ossiculoplasty: titanium versus PolycelChronic otitis media with ossicular disruption.Other acquired abnormalities of ear ossiclesIRCT2015082815496N19Vice Chancellor for Research, Shiraz University of Medical Sciences100
Completed
Not Applicable
Hearing impairment in pediatric patients receiving intravenous furosemide after cardiac surgeryHearing status in pediatric patients who undergo cardiac surgeryCongenital heart surgery, hearing impairment, diureticTCTR20200421001Faculty of Medicine185
Completed
Not Applicable
STUDY TO ASSESS HEARING LOSS IN PATIENTS RECEIVING SIMULTANEOUS CHEMOTHERAPY AND RADIATION THERAPY FOR HEAD AND NECK CANCERSCTRI/2014/08/004940FATHER MULLER MEDICAL COLLEGE50
Completed
Not Applicable
Hearing impairment in patients with OSMFHealth Condition 1: null- suffering with oral submucous fibrosisCTRI/2017/10/010161il200